View Grant Opportunity
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
National Institutes of Health
PAR-25-321
HHS-NIH11
General Information
N/a
Est. Program Funding:
Est. Program Funding:
January 7, 2028
Closing Date:
Closing Date:
N/a
Expected No. of Awards
Expected No. of Awards
N/a
Award Ceiling
Award Ceiling
Opportunity Number:
PAR-25-321
Owning Agency:
HHS-NIH11
Opportunity Category:
Discretionary (D)
Synopsis
| Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. | |
| Response Date | Jan 07, 2028 12:00:00 AM EST |
| Posting Date | Dec 10, 2024 12:00:00 AM EST |
| Archive Date | Feb 12, 2028 12:00:00 AM EST |
| Award Ceiling | N/a |
| Award Floor | N/a |
| Cost Sharing | No |
Eligibility
| Eligible Applicants | Independent school districts, Special district governments, Public and State controlled institutions of higher education, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Small businesses, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Private institutions of higher education, State governments, City or township governments, For profit organizations other than small businesses, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, County governments, Others (see text field entitled "Additional Information on Eligibility" for clarification) |
| Additional Info on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name | National Institutes of Health |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-25-321.html |
| Grantor Contact Information: |
If you have difficulty accessing the full announcement electronically, please contact:
GrantSolutions Help Desk Phone: 301-402-2541 |
CFDA Program(s)
- 93.393: Cancer Cause and Prevention Research
- 93.394: Cancer Detection and Diagnosis Research
- 93.395: Cancer Treatment Research
- 93.396: Cancer Biology Research
- 93.399: Cancer Control
Contact Us
Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.